Detalhe da pesquisa
1.
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
Proc Natl Acad Sci U S A
; 120(1): e2209944120, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574650
2.
Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS.
Acta Neuropathol
; 147(1): 82, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722375
3.
SKAP2 as a new regulator of oligodendroglial migration and myelin sheath formation.
Glia
; 69(11): 2699-2716, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324225
4.
One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2.
Stem Cell Reports
; 16(4): 771-783, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770499